Exactly mate. Too much upside when a stock hasn’t run yet. Happy to stick my money in a biotech that hasn’t run away yet. 30% is pretty good returns in a year....though 300% returns is alway possible when you put your money in a 40 million MC company. If you get in before the crowd it’s always easy to make profits. 1AD already has a commmercial collaboration with a trillion dollar revenue company in GE healthcare. 40 million MC collaborating with one of the largest healthcare companies in the world. If GE healthcare sees something in Adalta who am I to doubt? Will hold this one as long as they keep progressing like they are at the moment.
- Forums
- ASX - By Stock
- 1AD
- Ann: FDA Orphan Drug Designation for AD-214
Ann: FDA Orphan Drug Designation for AD-214, page-19
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AD (ASX) to my watchlist
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.48M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.6¢ | $16.56K | 636.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 237664 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 437561 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 237664 | 0.026 |
2 | 1312894 | 0.025 |
1 | 500000 | 0.024 |
1 | 29010 | 0.023 |
1 | 45450 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 437561 | 2 |
0.029 | 108304 | 2 |
0.035 | 138786 | 2 |
0.037 | 85000 | 1 |
0.045 | 306386 | 3 |
Last trade - 14.45pm 01/07/2024 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online